Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AAC Clyde Space AAC Mar 4, 2021 2.97 -4.81   
 AAK AAK Mar 4, 2021 185.95 +0.76   
 ABB ABB Mar 4, 2021 249.70 +0.20   
 Abelco Investment Group ABIG Mar 4, 2021 0.11 -1.82   
 ABG Sundal Collier Holding ABGO Mar 4, 2021 6.30 0.00   
 Abliva ABLI Mar 4, 2021 0.74 +2.92   
 Absolent Group ABSO Mar 4, 2021 399.00 +1.01   
 Absolicon ABSL Mar 4, 2021 139.00 -7.02   
 AcadeMedia ACAD Mar 4, 2021 86.30 -2.27   
 Acarix ACARIX Mar 4, 2021 1.21 -4.72   
 Acconeer ACCON Mar 4, 2021 29.50 -5.75   
 Acosense ACOS Mar 4, 2021 1.40 -2.10   
 AcouSort ACOU Mar 4, 2021 21.70 -3.98   
 Acrinova ACRI Mar 4, 2021 25.20 -3.08   
 ACROUD ACROUD Mar 4, 2021 2.83 0.00   
 Actic Group ATIC Mar 4, 2021 16.15 -3.29   
 Active Biotech ACTI Mar 4, 2021 1.56 -2.13   
 AcuCort ACUC Mar 4, 2021 5.24 -1.50   
 Adapteo ADAPT Mar 4, 2021 105.80 -1.49   
 AdderaCare ADDERA Mar 4, 2021 6.45 -3.73   
 AddLife B ALIFB Mar 4, 2021 172.20 -5.07   
 Addnode Group B ANODB Mar 4, 2021 240.50 -0.62   
 Addtech B ADDTB Mar 4, 2021 123.00 -2.38   
 ADDvise Group A ADDVA Mar 4, 2021 2.86 +16.26   
 ADDvise Group B ADDVB Mar 4, 2021 1.67 0.00   
 Adevinta ADEO Mar 4, 2021 135.10 0.00   
 Advenica ADVE Mar 4, 2021 4.91 -0.81   
 Adventure Box Technology ADVBOX Mar 4, 2021 6.64 -3.21   
 Adverty ADVT Mar 4, 2021 14.85 -4.19   
 Aegirbio AEGIR Mar 4, 2021 26.20 -0.38   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK